| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5831929 | International Immunopharmacology | 2016 | 9 Pages |
Abstract
mAb B60-55 is a potential candidate for clinical development in cancer treatment.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yan Luan, Dafei Chai, Jianjian Peng, Shuli Ma, Min Wang, Hui Ma, Xiang Li, Shilong Fu, Xiaolong Pan, Xiaoxiao Wang, Songbing Qin, Ting Xu,